menu
How The Biosensors Of Microfludics Reduces The Size,Cost And Assay Time?
How The Biosensors Of Microfludics Reduces The Size,Cost And Assay Time?
Clinical diagnostics is a significant application for Microfluidics. Multiple biochemical analysis procedures and symptom observation can be used to identify diseases, such as toxicity. Before visible damages of microscopic cells or other kinds of symptoms, changes in the blood of patients can indicate organ dysfunction or damage.

As a result of the enormous potentials of microfluidic technology, researchers can control fewer samples and reagents with greater efficiencies and generate results faster than traditional methods In the field of in-vitro diagnostics, Microfluidics is a new technology. Increased adoption of point-of-care diagnostics in various medical fields, as well as the emergence of 3D cell culture systems based on microfluidics, such as organ-on-a-chip, are driving the global  Point-of-care devices are small, portable instruments that are used to diagnose a variety of diseases. 

Diagnostic testing can be reduced in size, cost, and assay time by using microfluidics-based biosensors in proof-of-concept devices.The emergence of 3D microfluidic cell culture systems, such as organ-on-a-chip systems, is one of the new emerging applications of Microfluidics. Traditional animal studies and in-vitro culture systems have been helpful in understanding viral infection pathogenesis and facilitating vaccine development. However, there are still no models that closely resemble human responses to specific disease conditions.

 

Read More @ https://cmibloginsight.blogspot.com/2022/09/microfluidics-component-advancements.html